FRI0681 Clinical validation studies of the 2012 classification criteria for early rheumatoid arthritis (ERA) in a domestic multi-center cohort

Yaming Li, Wenqiang Fan, Hao Chen, Peiwu Yu, Huali Miao, Kairan Li, Jie Xu, Liufu Cui, G Zhang, Ke Xu, L Zhang, R LiAnnals 2017 · DOI

Introduction

Early diagnosis of Rheumatoid Arthritis (RA) is critical for initiating timely intervention to prevent irreversible joint damage and long-term disability. Historically, the 1987 ACR classification criteria served as the standard but were primarily designed for established disease, leading to low sensitivity in early-stage patients. While the 2010 ACR/EULAR criteria improved early detection, their complexity can hinder routine clinical use. The 2012 Early Rheumatoid Arthritis (ERA) criteria were developed to offer a more practical and sensitive alternative. This study aims to clinically validate the 2012 ERA criteria within a domestic multi-center cohort.

Methodology

This multi-center, cross-sectional study was conducted across five hospitals in China, enrolling 310 patients with early arthritis (symptom duration <1 year, age >16, and at least one swollen or tender joint). The "gold standard" for diagnosis was the consensus of two experienced rheumatologists. The diagnostic performance of the 1987 ACR, 2010 ACR/EULAR, and 2012 ERA criteria was evaluated by calculating sensitivity, specificity, and the Area Under the ROC Curve (AUC).

Patient Cohort Characteristics

The study cohort comprised 310 patients, categorized into 182 ERA cases and 128 non-RA controls. Demographic and clinical baseline data revealed significant differences between the groups.

Table 1: Demographic and clinical characteristics of the 310 patients with early arthritis.

As shown in Table 1, patients in the ERA group were significantly older (mean age 48.2 vs 42.8 years, p=0.002) and more likely to be female (76.9% vs 38.3%, p=0.000). Clinical markers of disease activity, including swollen joint count (SJC), tender joint count (TJC), and morning stiffness lasting ≥30 minutes, were significantly higher in the ERA group (p=0.000 for all).

Comparative Diagnostic Performance

The 2012 ERA criteria demonstrated high diagnostic accuracy, outperforming the 1987 ACR criteria and matching the performance of the 2010 ACR/EULAR criteria while offering greater simplicity.

Figure 1: ROC curves comparing the diagnostic performance of the 1987 ACR, 2010 ACR/EULAR, and 2012 ERA criteria.

The 2012 ERA criteria achieved a sensitivity of 88.5% and a specificity of 91.4%. In contrast, the 1987 ACR criteria showed a markedly lower sensitivity of 45.6%, failing to identify more than half of the early RA cases. While the 2010 ACR/EULAR criteria had a slightly higher sensitivity (91.8%), the difference was not statistically significant compared to the 2012 ERA criteria. Notably, the 2012 ERA criteria yielded the highest overall diagnostic accuracy with an AUC of 0.962, compared to 0.959 for the 2010 criteria and 0.885 for the 1987 criteria.

Conclusion

The 2012 ERA classification criteria provide a highly sensitive and specific tool for the early detection of RA. By significantly outperforming the 1987 ACR standards and maintaining comparable accuracy to the 2010 ACR/EULAR criteria with a simpler application, the 2012 ERA criteria are well-suited for clinical practice. These findings support their use in identifying patients during the optimal therapeutic window, facilitating "treat-to-target" strategies in early arthritis.

Summary updated

BibTeX
@article{li2017fri,
  author = {Yaming Li and Wenqiang Fan and Hao Chen and Peiwu Yu and Huali Miao and Kairan Li and Jie Xu and Liufu Cui and G Zhang and Ke Xu and L Zhang and R Li},
  title = {{FRI0681 Clinical validation studies of the 2012 classification criteria for early rheumatoid arthritis (ERA) in a domestic multi-center cohort}},
  journal = {Annals},
  year = {2017},
  doi = {10.1136/annrheumdis-2017-eular.3112},
}
Figure